CysLT2 Receptors Interact with CysLT1 Receptors and Down-modulate Cysteinyl Leukotriene Dependent Mitogenic Responses of Mast Cells

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2007 Aug 19

PMID 17693579

Citations 63

Authors

Yongfeng Jiang

Laura A Borrelli

Yoshihide Kanaoka

Brian J Bacskai

Joshua A Boyce

Affiliations

Soon will be listed here.

Abstract

Cysteinyl leukotrienes (cys-LTs) induce inflammation through 2 G protein-coupled receptors (GPCRs), CysLT(1) and CysLT(2), which are coexpressed by most myeloid cells. Cys-LTs induce proliferation of mast cells (MCs), transactivate c-Kit, and phosphorylate extracellular signal-regulated kinase (ERK). Although MCs express CysLT(2), their responses to cys-LTs are blocked by antagonists of CysLT(1). We demonstrate that CysLT(2) interacts with CysLT(1), and that knockdown of CysLT(2) increases CysLT(1) surface expression and CysLT(1)-dependent proliferation of cord blood-derived human MCs (hMCs). Cys-LT-mediated responses were absent in MCs from mice lacking CysLT(1) receptors, but enhanced by the absence of CysLT(2) receptors. CysLT(1) and CysLT(2) receptors colocalized to the plasma membranes and nuclei of a human MC line, LAD2. Antibody-based fluorescent lifetime imaging microscopy confirmed complexes containing both receptors based on fluorescence energy transfer. Negative regulation of CysLT(1)-induced mitogenic signaling responses of MCs by CysLT(2) demonstrates physiologically relevant functions for GPCR heterodimers on primary cells central to inflammation.

Citing Articles

Cysteinyl Leukotrienes in Allergic Inflammation.

Lee M, Boyce J, Barrett N Annu Rev Pathol. 2024; 20(1):115-141.

PMID: 39374430 PMC: 11759657. DOI: 10.1146/annurev-pathmechdis-111523-023509.

A critical role for Macrophage-derived Cysteinyl-Leukotrienes in HIV-1 induced neuronal injury.

Yuan N, Medders K, Sanchez A, Shah R, de Rozieres C, Ojeda-Juarez D Brain Behav Immun. 2024; 118:149-166.

PMID: 38423397 PMC: 11173376. DOI: 10.1016/j.bbi.2024.02.023.

Regulatory Roles of Phospholipase A Enzymes and Bioactive Lipids in Mast Cell Biology.

Taketomi Y, Murakami M Front Immunol. 2022; 13:923265.

PMID: 35833146 PMC: 9271868. DOI: 10.3389/fimmu.2022.923265.

A Dual Role for Cysteinyl Leukotriene Receptors in the Pathogenesis of Corneal Infection.

Carion T, Wang Y, Stambersky A, Ebrahim A, Berger E J Immunol. 2022; 208(10):2331-2342.

PMID: 35470258 PMC: 9117469. DOI: 10.4049/jimmunol.2100474.

A review of non-prostanoid, eicosanoid receptors: expression, characterization, regulation, and mechanism of action.

Biringer R J Cell Commun Signal. 2021; 16(1):5-46.

PMID: 34173964 PMC: 8688645. DOI: 10.1007/s12079-021-00630-6.

References

Mellor E, Maekawa A, Austen K, Boyce J . Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proc Natl Acad Sci U S A. 2001; 98(14):7964-9. PMC: 35451. DOI: 10.1073/pnas.141221498. View

Heise C, ODowd B, Figueroa D, Sawyer N, Nguyen T, Im D . Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem. 2000; 275(39):30531-6. DOI: 10.1074/jbc.M003490200. View

Maekawa A, Austen K, Kanaoka Y . Targeted gene disruption reveals the role of cysteinyl leukotriene 1 receptor in the enhanced vascular permeability of mice undergoing acute inflammatory responses. J Biol Chem. 2002; 277(23):20820-4. DOI: 10.1074/jbc.M203163200. View

Kirshenbaum A, Akin C, Wu Y, Rottem M, Goff J, Beaven M . Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcepsilonRI or FcgammaRI. Leuk Res. 2003; 27(8):677-82. DOI: 10.1016/s0145-2126(02)00343-0. View

Berezovska O, Ramdya P, Skoch J, Wolfe M, Bacskai B, Hyman B . Amyloid precursor protein associates with a nicastrin-dependent docking site on the presenilin 1-gamma-secretase complex in cells demonstrated by fluorescence lifetime imaging. J Neurosci. 2003; 23(11):4560-6. PMC: 6740808. View

Bacskai B, Skoch J, Hickey G, Allen R, Hyman B . Fluorescence resonance energy transfer determinations using multiphoton fluorescence lifetime imaging microscopy to characterize amyloid-beta plaques. J Biomed Opt. 2003; 8(3):368-75. DOI: 10.1117/1.1584442. View

Figueroa D, Borish L, Baramki D, Philip G, Austin C, Evans J . Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis. Clin Exp Allergy. 2003; 33(10):1380-8. DOI: 10.1046/j.1365-2222.2003.01786.x. View

Mellor E, Frank N, Soler D, Hodge M, Lora J, Austen K . Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R. Proc Natl Acad Sci U S A. 2003; 100(20):11589-93. PMC: 208802. DOI: 10.1073/pnas.2034927100. View

Calver A, Robbins M, Cosio C, Rice S, Babbs A, Hirst W . The C-terminal domains of the GABA(b) receptor subunits mediate intracellular trafficking but are not required for receptor signaling. J Neurosci. 2001; 21(4):1203-10. PMC: 6762247. View

10.

Kanaoka Y, Maekawa A, Penrose J, Austen K, Lam B . Attenuated zymosan-induced peritoneal vascular permeability and IgE-dependent passive cutaneous anaphylaxis in mice lacking leukotriene C4 synthase. J Biol Chem. 2001; 276(25):22608-13. DOI: 10.1074/jbc.M103562200. View

11.

Beller T, Friend D, Maekawa A, Lam B, Austen K, Kanaoka Y . Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. Proc Natl Acad Sci U S A. 2004; 101(9):3047-52. PMC: 365742. DOI: 10.1073/pnas.0400235101. View

12.

Mandal A, Skoch J, Bacskai B, Hyman B, Christmas P, Miller D . The membrane organization of leukotriene synthesis. Proc Natl Acad Sci U S A. 2004; 101(17):6587-92. PMC: 404089. DOI: 10.1073/pnas.0308523101. View

13.

Breit A, Lagace M, Bouvier M . Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties. J Biol Chem. 2004; 279(27):28756-65. DOI: 10.1074/jbc.M313310200. View

14.

Lleo A, Berezovska O, Herl L, Raju S, Deng A, Bacskai B . Nonsteroidal anti-inflammatory drugs lower Abeta42 and change presenilin 1 conformation. Nat Med. 2004; 10(10):1065-6. DOI: 10.1038/nm1112. View

15.

Pillai S, Cousens D, Barnes A, Buckley P, Chiano M, Hosking L . A coding polymorphism in the CYSLT2 receptor with reduced affinity to LTD4 is associated with asthma. Pharmacogenetics. 2004; 14(9):627-33. DOI: 10.1097/00008571-200409000-00007. View

16.

Beller T, Maekawa A, Friend D, Austen K, Kanaoka Y . Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice. J Biol Chem. 2004; 279(44):46129-34. DOI: 10.1074/jbc.M407057200. View

17.

Kitamura Y, Go S, Hatanaka K . Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood. 1978; 52(2):447-52. View

18.

Casale T, Wood D, Richerson H, Zehr B, Zavala D, Hunninghake G . Direct evidence of a role for mast cells in the pathogenesis of antigen-induced bronchoconstriction. J Clin Invest. 1987; 80(5):1507-11. PMC: 442412. DOI: 10.1172/JCI113234. View

19.

Molfino N, Slutsky A, Hoffstein V, McClean P, Rebuck A, Drazen J . Changes in cross-sectional airway areas induced by methacholine, histamine, and LTC4 in asthmatic subjects. Am Rev Respir Dis. 1992; 146(3):577-80. DOI: 10.1164/ajrccm/146.3.577. View

20.

Hamilton A, Faiferman I, STOBER P, Watson R, OByrne P . Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects. J Allergy Clin Immunol. 1998; 102(2):177-83. DOI: 10.1016/s0091-6749(98)70083-1. View